One year after its FDA approval for HF treatment, a new FINEARTS-HF substudy shows Bayer’s Kerendia (finerenone) isn’t just impervious to BP differences, it could actually give a small leg up to patients with hypertension.  A FINEARTS-HF refresher: The trial randomized 6k patients with HFmrEF/HFpEF to treatment with either Kerendia or placebo. Now this substudy […] The post Can Kerendia Handle the (Blood) Pressure? More Findings from FINEARTS-HF. appeared first on Cardiac Wire .